Literature DB >> 18410501

Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression.

Lydiane Funkelstein1, Thomas Toneff, Shin-Rong Hwang, Thomas Reinheckel, Christoph Peters, Vivian Hook.   

Abstract

Neuropeptide Y (NPY) functions as a peptide neurotransmitter and as a neuroendocrine hormone. The active NPY peptide is generated in secretory vesicles by proteolytic processing of proNPY. Novel findings from this study show that cathepsin L participates as a key proteolytic enzyme for NPY production in secretory vesicles. Notably, NPY levels in cathepsin L knockout (KO) mice were substantially reduced in brain and adrenal medulla by 80% and 90%, respectively. Participation of cathepsin L in producing NPY predicts their colocalization in secretory vesicles, a primary site of NPY production. Indeed, cathepsin L was colocalized with NPY in brain cortical neurons and in chromaffin cells of adrenal medulla, demonstrated by immunofluorescence confocal microscopy. Immunoelectron microscopy confirmed the localization of cathepsin L with NPY in regulated secretory vesicles of chromaffin cells. Functional studies showed that coexpression of proNPY with cathepsin L in neuroendocrine PC12 cells resulted in increased production of NPY. Furthermore, in vitro processing indicated cathepsin L processing of proNPY at paired basic residues. These findings demonstrate a role for cathepsin L in the production of NPY from its proNPY precursor. These studies illustrate the novel biological role of cathepsin L in the production of NPY, a peptide neurotransmitter, and neuroendocrine hormone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18410501      PMCID: PMC2661760          DOI: 10.1111/j.1471-4159.2008.05408.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  32 in total

Review 1.  The role of neuropeptide Y in cardiovascular regulation.

Authors:  P Walker; E Grouzmann; M Burnier; B Waeber
Journal:  Trends Pharmacol Sci       Date:  1991-03       Impact factor: 14.819

2.  Altered processing of pro-orphanin FQ/nociceptin and pro-opiomelanocortin-derived peptides in the brains of mice expressing defective prohormone convertase 2.

Authors:  R G Allen; B Peng; M J Pellegrino; E D Miller; D K Grandy; J R Lundblad; C L Washburn; J E Pintar
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

Review 3.  Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L.

Authors:  T Reinheckel; J Deussing; W Roth; C Peters
Journal:  Biol Chem       Date:  2001-05       Impact factor: 3.915

4.  An aminopeptidase activity in bovine pituitary secretory vesicles that cleaves the N-terminal arginine from beta-lipotropin60-65.

Authors:  H Gainer; J T Russell; Y P Loh
Journal:  FEBS Lett       Date:  1984-09-17       Impact factor: 4.124

5.  Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter.

Authors:  Sukkid Yasothornsrikul; Doron Greenbaum; Katalin F Medzihradszky; Thomas Toneff; Richard Bundey; Ruthellen Miller; Birgit Schilling; Ivonne Petermann; Jessica Dehnert; Anna Logvinova; Paul Goldsmith; John M Neveu; William S Lane; Bradford Gibson; Thomas Reinheckel; Christoph Peters; Matthew Bogyo; Vivian Hook
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-17       Impact factor: 11.205

6.  Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects.

Authors:  Xiaorong Zhu; An Zhou; Arunangsu Dey; Christina Norrbom; Raymond Carroll; Chunling Zhang; Virginie Laurent; Iris Lindberg; Randi Ugleholdt; Jens J Holst; Donald F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

7.  Obliteration of alpha-melanocyte-stimulating hormone derived from POMC in pituitary and brains of PC2-deficient mice.

Authors:  Ruthellen Miller; Wade Aaron; Thomas Toneff; Daesety Vishnuvardhan; Margery C Beinfeld; Vivian Y H Hook
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

8.  Biosynthesis of proopiomelanocortin-derived peptides in prohormone convertase 2 and 7B2 null mice.

Authors:  Virginie Laurent; Lisa Jaubert-Miazza; Roxane Desjardins; Robert Day; Iris Lindberg
Journal:  Endocrinology       Date:  2003-10-23       Impact factor: 4.736

9.  Rat neuropeptide Y precursor gene expression. mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP, and phorbol ester.

Authors:  H Higuchi; H Y Yang; S L Sabol
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

Review 10.  Carboxypeptidase E.

Authors:  L D Fricker
Journal:  Annu Rev Physiol       Date:  1988       Impact factor: 19.318

View more
  26 in total

Review 1.  Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides.

Authors:  Lydiane Funkelstein; Margery Beinfeld; Ardalan Minokadeh; James Zadina; Vivian Hook
Journal:  Neuropeptides       Date:  2010-11-02       Impact factor: 3.286

2.  Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesis.

Authors:  Xin Zhang; Hui Pan; Bonnie Peng; Donald F Steiner; John E Pintar; Lloyd D Fricker
Journal:  J Neurochem       Date:  2009-12-07       Impact factor: 5.372

3.  Genes and environment: novel, functional polymorphism in the human cathepsin L (CTSL1) promoter disrupts a xenobiotic response element (XRE) to alter transcription and blood pressure.

Authors:  Nzali Mbewe-Campbell; Zhiyun Wei; Kuixing Zhang; Ryan S Friese; Manjula Mahata; Andrew J Schork; Fangwen Rao; Stephane Chiron; Nilima Biswas; Hyung-Suk Kim; Sushil K Mahata; Jill Waalen; Caroline M Nievergelt; Vivian Y Hook; Daniel T O'Connor
Journal:  J Hypertens       Date:  2012-10       Impact factor: 4.844

4.  Spinal astrocytes produce and secrete dynorphin neuropeptides.

Authors:  Andrew Wahlert; Lydiane Funkelstein; Bethany Fitzsimmons; Tony Yaksh; Vivian Hook
Journal:  Neuropeptides       Date:  2013-01-03       Impact factor: 3.286

5.  Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.

Authors:  Hatem A Elshabrawy; Jilao Fan; Christine S Haddad; Kiira Ratia; Christopher C Broder; Michael Caffrey; Bellur S Prabhakar
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

6.  Human cathepsin V protease participates in production of enkephalin and NPY neuropeptide neurotransmitters.

Authors:  Lydiane Funkelstein; W Douglas Lu; Britta Koch; Charles Mosier; Thomas Toneff; Laurent Taupenot; Daniel T O'Connor; Thomas Reinheckel; Christoph Peters; Vivian Hook
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

Review 7.  Neuropeptidomic components generated by proteomic functions in secretory vesicles for cell-cell communication.

Authors:  Vivian Hook; Steven Bark; Nitin Gupta; Mark Lortie; Weiya D Lu; Nuno Bandeira; Lydiane Funkelstein; Jill Wegrzyn; Daniel T O'Connor; Pavel Pevzner
Journal:  AAPS J       Date:  2010-08-24       Impact factor: 4.009

Review 8.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

9.  The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.

Authors:  Bailey Miller; Aaron J Friedman; Hyukjae Choi; James Hogan; J Andrew McCammon; Vivian Hook; William H Gerwick
Journal:  J Nat Prod       Date:  2013-12-23       Impact factor: 4.050

10.  Proteolytic fragments of chromogranins A and B represent major soluble components of chromaffin granules, illustrated by two-dimensional proteomics with NH(2)-terminal Edman peptide sequencing and MALDI-TOF MS.

Authors:  Jean C Lee; Vivian Hook
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.